Gallbladder cancer (GBC) is a relatively rare occurrence with a poor prognosis (overall 5-
year survival is 50% for stage I cancers and 3% for stage IV cancers 1). Surgical resection is …

Background Gallbladder cancer is rare, but cancers detected incidentally after
cholecystectomy are increasing. The aim of this study was to review the available data for …

Abstract Background The Japanese Society of Hepato‐Biliary‐Pancreatic Surgery launched
the clinical practice guidelines for the management of biliary tract cancers …

Early-stage gallbladder cancer (GBC) is mostly discovered incidentally by the pathologist
after cholecystectomy for a presumed benign disease. It is the most common malignancy of …

Gallbladder cancer is the most common biliary tract malignancy. Margin-clearing surgery is
a cornerstone of gallbladder cancer management, but several aspects of surgical …

Background Re-resection for incidental gallbladder cancer (iGBC) is associated with
improved survival but little is known about residual disease (RD) and prognostic factors. In …

Die Leitlinie zur Prävention, Diagnostik und Therapie von Gallensteinen aktualisiert die
Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …

Given the rarity of gallbladder carcinoma, level I evidence to guide the multimodal treatment
of this disease is lacking. Since 2010, four randomized phase III clinical trials including ABC …

Gallbladder cancer is a rare, aggressive malignancy that has a poor overall prognosis.
Effective treatment consists of early detection and surgical treatment. With the wide spread …

Primary cancers of the liver and biliary tract are rare and aggressive tumors that often
present with locally advanced or metastatic disease. For patients with localized disease …